10-Q: Este Lauder Reports Mixed Q2 Results Amidst Restructuring Announcement

Sentiment:

Quarterly Report


Este Lauder's second quarter results show a decrease in net sales and earnings, alongside the announcement of a significant restructuring plan.

Worse than expectedThe company's net sales and earnings were lower than the prior year period.The company is experiencing challenges in key markets such as Asia travel retail and mainland China.The company's gross margin declined due to higher obsolescence charges and manufacturing costs.

Summary

  • Este Lauder's net sales decreased by 7% to $4.28 billion for the three months ended December 31, 2023, and by 9% to $7.8 billion for the six months ended December 31, 2023.
  • The company's operating income was $574 million for the quarter and $672 million for the six-month period.
  • Net earnings attributable to Este Lauder were $313 million for the quarter and $344 million for the six-month period.
  • The company announced a two-year restructuring program expected to incur charges between $500 million and $700 million, with anticipated annual gross benefits between $350 million and $500 million.
  • The restructuring program includes a net reduction of approximately 1,800 to 3,000 positions globally.
  • The company experienced challenges in its Asia travel retail business and ongoing softness in overall prestige beauty in mainland China.

Sentiment

Score: 4

Explanation: The document presents a mix of negative and positive aspects. The negative aspects, such as declining sales, restructuring, and challenges in key markets, outweigh the positives, such as growth in certain brands and regions. The overall sentiment is cautious and indicates a need for significant improvements.

Positives

  • The Ordinary brand showed growth in every geographic region.
  • Le Labo and Jo Malone London fragrance brands experienced higher net sales.
  • Latin America, particularly Brazil and Mexico, saw increased net sales.
  • The company is taking steps to enhance the security of its systems following a cybersecurity incident.

Negatives

  • Este Lauder and Clinique brands experienced lower net sales in skin care.
  • MAC and Este Lauder brands saw lower net sales in makeup.
  • Aveda brand experienced lower net sales in hair care.
  • The company's Asia travel retail business is facing significant challenges.
  • Mainland China market is experiencing ongoing softness in prestige beauty.
  • Gross margin decreased to 73.0% and 71.5% for the three and six months ended December 31, 2023, respectively.
  • The company experienced under absorption of manufacturing variances due to lower production volumes.

Risks

  • The company faces ongoing challenges in its Asia travel retail business and mainland China market.
  • The company is experiencing business disruption in Israel and other parts of the Middle East.
  • The company is monitoring the effects of the global macro environment, including the risk of recession, currency volatility, and inflationary pressures.
  • The company is mindful of geopolitical tensions between the United States and China.
  • A decline in net sales and profitability may adversely impact the goodwill and other intangible assets associated with our brands, as well as long-lived assets, potentially resulting in impairments.

Future Outlook

The company expects continued challenges in its Asia travel retail business and mainland China, as well as business disruptions in Israel and other parts of the Middle East, which are expected to negatively impact net sales and profitability. The company also anticipates under absorption of manufacturing variances due to lower production volumes and is evaluating its inventory position, which could result in increased charges in future periods.

Management Comments

  • The company has launched a Profit Recovery Plan to help progressively rebuild its profit margins in fiscal years 2025 and 2026.
  • The restructuring program's main focus includes the reorganization and rightsizing of certain areas of the company as well as simplification and acceleration of processes.
  • The company plans to substantially complete specific initiatives under the restructuring program through fiscal 2026.

Industry Context

The results reflect broader challenges in the prestige beauty sector, particularly in Asia, and highlight the impact of travel retail disruptions and changing consumer preferences. The restructuring plan indicates a strategic shift to improve profitability and adapt to these market changes.

Comparison to Industry Standards

  • The decline in net sales and operating income is worse than some competitors in the beauty industry who have shown resilience in certain markets.
  • The restructuring plan is similar to actions taken by other companies facing similar challenges in the current economic environment.
  • The company's performance in Asia is notably weaker compared to some competitors who have maintained stronger growth in the region.
  • The company's gross margin decline is more pronounced than some peers, indicating potential issues with cost management and pricing strategies.

Legal Proceedings

  • The company and its Chief Executive Officer and Chief Financial Officer were named as defendants in separate purported securities class action complaints.
  • A shareholder derivative action complaint was filed against certain of the company's officers and directors.

Stakeholder Impact

  • Shareholders will be impacted by the decrease in net sales and earnings, as well as the restructuring program.
  • Employees will be impacted by the restructuring program, which includes a net reduction of approximately 1,800 to 3,000 positions globally.
  • Customers may experience changes in product availability and pricing due to the restructuring program.
  • Suppliers may be impacted by changes in the company's operations and supply chain.

Next Steps

  • The company plans to substantially complete specific initiatives under the restructuring program through fiscal 2026.
  • The company will continue to monitor the effects of the global macro environment.
  • The company will continue to take steps to enhance the security of its systems following a cybersecurity incident.

Key Dates

DateDescription
June 30, 2022License terminations related to certain designer fragrances became effective.
August 16, 2022The U.S. federal government enacted the Inflation Reduction Act.
November 30, 2022Interim impairment tests for trademarks and a recoverability test for long-lived assets were performed for Dr.Jart+ and Too Faced.
December 2022The company temporarily suspended the repurchase of shares of its Class A Common Stock.
July 18, 2023The company identified a cybersecurity incident.
August 17, 2023A dividend of $0.66 per share was declared.
October 31, 2023A dividend of $0.66 per share was declared.
November 1, 2023The company launched a Profit Recovery Plan.
December 7, 2023The company and its executives were named as defendants in a securities class action complaint.
December 31, 2023End of the reporting period for the quarterly report.
January 22, 2024The company and its executives were named as defendants in a second securities class action complaint.
January 29, 2024Shares of Class A and Class B common stock outstanding.
February 1, 2024The company committed to a two-year restructuring program and a shareholder derivative action complaint was filed.
February 2, 2024A dividend of $0.66 per share was declared.
February 5, 2024The company announced a two-year restructuring program and the date of the 10-Q filing.

Keywords

restructuring, net sales, operating income, Asia travel retail, mainland China, prestige beauty, financial results, impairment, cost reduction, profitability

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.